Randomized, Open-Label Phase 2 Study of Apalutamide Plus Androgen Deprivation Therapy Versus Apalutamide Monotherapy Versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
Prostate Cancer(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要